Yusuke Tomita

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuhiko Hattori, Kazuhiko Kurozumi, Yoshihiro Otani, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Kentaro Fujii, Yusuke Tomita, Tetsuo Oka, Yuji Matsumoto, Yosuke Shimazu, Hiroyuki Michiue, Hiromi Kumon, Isao Date
Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis. PloS one 17 (8) (2022)
Yusuke Tomita, Yosuke Shimazu, Agila Somasundaram, Yoshihiro Tanaka, Nozomu Takata, Yukitomo Ishi, Samantha Gadd, Rintaro Hashizume, Angelo Angione, Gonzalo Pinero, Dolores Hambardzumyan, Daniel J Brat, Christine M Hoeman, Oren J Becher
A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M. Glia 70 (9) (2022)
Yusuke Tomita, Yoshihiro Tanaka, Nozomu Takata, Elizabeth A Hibler, Rintaro Hashizume, Oren Josh Becher
Fifteen-year trends and differences in mortality rates across sex, age, and race/ethnicity in patients with brainstem tumors. Neuro-oncology advances 3 (1) (2021)

Yusuke Tomita.css-eqlu8i{font-size:small;padding-left:4px;}